Katie Swanton
Medical · Beaumont, TXNPI 1952568909
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AstraZeneca at 30.1% of the total. 2025 is the largest year on record at $1,807, 5.0 times the $361 reported in 2021.
Across 164 payments — averaging $20.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Amgen$198
- Novartis$198
- Regeneron Healthcare Solutions, Inc.$191
- Sanofi$182
- Incyte Corporation$172
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,29499%
- Education$341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 47 | $1,002 |
| Amgen | 9 | $198 |
| Novartis | 11 | $198 |
| Regeneron Healthcare Solutions, Inc. | 9 | $191 |
| Sanofi | 8 | $182 |
| Incyte Corporation | 8 | $172 |
| Genentech USA, Inc. | 4 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $150 |
| Pharming Healthcare, Inc. | 7 | $145 |
| CSL Behring | 5 | $118 |
| AbbVie | 5 | $90 |
| Novo Nordisk | 7 | $90 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $88 |
| Amarin Pharma, Inc. | 3 | $59 |
| Ionis Pharmaceuticals, Inc. | 3 | $58 |
| Lilly USA, LLC | 3 | $57 |
| Merck | 3 | $45 |
| Organon | 3 | $44 |
| Kaleo, Inc. | 2 | $41 |
| Optinose US, Inc. | 3 | $39 |
| Galderma Laboratories, L.p. | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Pfizer | 2 | $29 |
| Daiichi Sankyo Inc. | 2 | $27 |
| X4 Pharmaceuticals, Inc. | 1 | $25 |
| LEO Pharma Inc. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $15 |
How this compares
$3,328 in reported general payments places this provider in the 75th percentile of 1,490 medical providers in Texas.
Other medical in Beaumont
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
- Courtney AldridgeSan Antonio$89K
- Janine ShinnDallas$84K
- Radha BernanderKaty$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.